The immunology of chickenpox: A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection

Journal of Infection

Volumn 36, Issue SUPPL. 1, 1998, Pages 11-16

  Goldblatt, D ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN CLASS; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY AFFINITY; BIOSYNTHESIS; CELLULAR IMMUNITY; CHICKENPOX; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; REVIEW; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; CHICKENPOX; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN ISOTYPES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 17544393058     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0163-4453(98)80150-3     Document Type: Article

References (21)

1. Myers MG, Connelly B. Animal models of varicella. J Infect Dis 1992; 166: S48.
2. Morag A, Gershon A. Advances in pediatric infectious diseases: varicella zoster virus. In: Engelhard Marks MI, Branski D, eds. Pediatric infectious diseases. Basel: Karger, 1993: 27-36.
3. Grose C. Variation on a theme by Fenner: the pathogenesis of chicken-pox. Pediatrics 1981; 68: 735.
4. Gershon A A, Steinberg AP, Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis 1984; 149: 137.
5. Junker AK, Angus E, Thomas EE. Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr Infect Dis J 1991; 10: 569.
6. Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control and importance of a not-so-benign virus. N Engl J Med 1983; 309: 1362
7. Williams V, Gershon AA, Brunell PA. Serologic response to varicella-zoster membrane antigens measured by immunofluorescence. J Infect Dis 1974; 130: 669
8. Shehab Z, Brunell PA. Enzyme-linked immunosorbent assay for susceptibility to varicella. J Infect Dis 1983; 148: 472.
9. Keller P, Lonergan K, Neff B, Morton D, Ellis R. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII and gpIII and their use in ELISA for detection of VZV-glycoprotein-specific antibodies. J Virol Meth 1986; 14: 177.
10. Provost PJ, Krah DL, Kuter BJ et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991; 9: 111.
11. Steinberg SP, Gershon AA. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J Clin Microbiol 1991; 29: 1527.
12. Landry ME, Ferguson D. Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol 1993; 31: 3031.
13. Arvin AM. Cell-mediated immunity to varicella-zoster virus. J Infect Dis 1992; 166 (Suppl.): S35-S41.
14. Forghani B, Ni L, Grose C. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 1994; 199: 458-462.
15. Grose C. Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs. Rev Infect Dis 1991; 13(Suppl. 11): S960-S963.
16. Harper DR, Kangro HO, Health RB. Serological responses in varicella and zoster assayed by immunoblotting. J Med Virol 1988; 25: 387-398.
17. Harper DR, Grose C. IgM and IgG responses to varicella-zoster virus p32/p36 complex following chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis 1989; 159: 444-451.
18. Weigle KA, Grose C. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis 1984; 149: 741-749.
19. Arvin AM, Solem SM, Koropchak CM, Kinney-Thomas E, Paryani SG. Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and a non-glycosylated protein, P170, in the strain 2 guinea-pig. J Gen Virol 1987; 68: 2499.
20. Brunell PA, Novelli VA, Keller PM, Ellis RW. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis 1987; 156: 430.
21. Vafai A, Yang W. Neutralising antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV. J Virol 1991; 65: 5593.